Samir S Taneja Selected Research

Photochemotherapy (Photodynamic Therapy)

1/2017	Re: Padeliporfin Vascular-Targeted Photodynamic Therapy versus Active Surveillance in Men with Low-Risk Prostate Cancer (CLIN1001 PCM301): An Open-Label, Phase 3, Randomised Controlled Trial.
10/2016	Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samir S Taneja Research Topics

Disease

206	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 02/2002
69	Neoplasms (Cancer) 12/2023 - 10/2002
22	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 08/2003
13	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2004
10	Carcinoma (Carcinomatosis) 01/2019 - 03/2006
6	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 03/2010
5	Margins of Excision 01/2023 - 02/2009
4	Prostatic Intraepithelial Neoplasia 02/2013 - 10/2002
3	Extranodal Extension 01/2020 - 10/2002
3	Pain (Aches) 08/2015 - 05/2013
3	Kidney Neoplasms (Kidney Cancer) 10/2012 - 03/2008
2	Circulating Neoplastic Cells 10/2016 - 01/2009
2	Obesity 03/2016 - 04/2006
2	Ischemia 07/2012 - 11/2011
2	Renal Insufficiency (Renal Failure) 06/2009 - 08/2003
2	Lymphadenopathy 03/2008 - 05/2004
2	Disease Progression 11/2007 - 12/2005
1	Urogenital Neoplasms 11/2023
1	Testicular Neoplasms (Testicular Cancer) 11/2023
1	Urinary Incontinence 01/2023
1	Surgical Wound Infection 10/2022
1	Septic Shock (Toxic Shock Syndrome) 10/2022
1	Genetic Risk Score 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Malnutrition (Nutritional Deficiencies) 01/2018
1	Frailty 01/2018

Drug/Important Bio-Agent (IBA)

38	Prostate-Specific Antigen (Semenogelase)IBA 01/2023 - 10/2002
30	AndrogensIBA 10/2020 - 02/2002
11	enzalutamideIBA 11/2020 - 01/2013
10	Hormones (Hormone)IBA 11/2018 - 01/2003
9	Biomarkers (Surrogate Marker)IBA 09/2019 - 03/2006
8	Docetaxel (Taxotere)FDA Link 01/2018 - 12/2013
6	AntigensIBA 01/2023 - 01/2004
6	abirateroneIBA 01/2020 - 09/2013
6	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 04/2004
5	Proteins (Proteins, Gene)FDA Link 04/2009 - 02/2002
4	Testosterone (Sustanon)FDA Link 01/2017 - 04/2006
4	Toremifene (Fareston)FDA Link 08/2013 - 01/2005
4	Sunitinib (Sutent)FDA Link 12/2012 - 04/2012
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2016
3	Androgen Antagonists (Antiandrogens)IBA 11/2020 - 04/2009
3	olaparibIBA 10/2020 - 01/2016
3	cabazitaxel FDA Link 01/2020 - 12/2013
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 05/2014
3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 05/2012
3	Abiraterone AcetateIBA 01/2016 - 05/2013
3	Kallikreins (Kallikrein)IBA 12/2015 - 01/2015
3	Prednisone (Sone)FDA LinkGeneric 10/2015 - 05/2013
3	Estrogens (Estrogen)FDA Link 04/2006 - 01/2005
2	Prostaglandins AIBA 08/2022 - 02/2016
2	gallium 68 PSMA-11IBA 01/2020 - 12/2017
2	Gemcitabine FDA Link 01/2018 - 05/2012
2	Zoledronic Acid (Zometa)FDA Link 01/2017 - 10/2016
2	padeliporfinIBA 01/2017 - 10/2016
2	Cell-Free Nucleic AcidsIBA 01/2017 - 09/2015
2	bicalutamide (Casodex)FDA LinkGeneric 01/2017 - 01/2016
2	Leuprolide (Lupron)FDA LinkGeneric 06/2015 - 05/2013
2	Radium-223IBA 03/2015 - 03/2014
2	Soybean Proteins (Soy Protein)IBA 01/2014 - 07/2013
2	Dutasteride (Avodart)FDA Link 05/2013 - 11/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2012 - 04/2012
2	Sorafenib (BAY 43-9006)FDA Link 12/2012 - 08/2012
2	Neprilysin (Neutral Endopeptidase)IBA 12/2006 - 06/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2006 - 06/2004
1	Dihydrotachysterol (AT 10)IBA 12/2023
1	SmokeIBA 01/2023
1	Hematoxylin (Haematoxylon)IBA 01/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2023
1	fluciclovine F-18IBA 11/2022
1	Lutetium-177IBA 01/2020
1	GoldIBA 01/2020
1	PSMA-617IBA 01/2020
1	darolutamideIBA 10/2019
1	apalutamideIBA 10/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	MicroRNAs (MicroRNA)IBA 11/2018
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2018
1	Sodium Fluoride (Ossin)FDA Link 06/2018
1	cyclo(Arg-Pro) (CI 4)IBA 05/2018
1	Circulating Tumor DNAIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 12/2017

Therapy/Procedure

59	Therapeutics 12/2023 - 05/2004
59	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 10/2002
28	Radiotherapy 11/2023 - 06/2008
28	Castration 11/2020 - 12/2005
22	Nephrectomy 02/2019 - 08/2003
10	Drug Therapy (Chemotherapy) 01/2023 - 01/2005
10	Nephroureterectomy 01/2019 - 01/2009
5	Lymph Node Excision (Lymph Node Dissection) 11/2023 - 05/2004
5	Cystectomy 01/2023 - 01/2018
3	Cryosurgery 12/2023 - 08/2022
2	Operative Time 01/2023 - 03/2008
2	Operative Surgical Procedures 02/2019 - 01/2017
2	Neoadjuvant Therapy 01/2019 - 01/2018
2	Photochemotherapy (Photodynamic Therapy) 01/2017 - 10/2016
1	Catheters 01/2023
1	Salvage Therapy 01/2023
1	Mechanical Ventilators (Ventilator) 10/2022
1	Precision Medicine 01/2020
1	Immunotherapy 11/2017